AKESO BIOPHARMA
The company has built a global level of bio-pharmaceutical research and development and industrialization platform; established for cancer, autoimmune diseases, inflammation and cardiovascular disease of the rich product line. The scale of the company's platform, hardware and software facilities, the number of new drug product lines, R & D team in the country are the same industry-leading level. Kang Fang biological has been with the international and domestic listed pharmaceutical companies to establish a cooperative relationship, the joint development of innovative antibodies to new drugs, is a strategic cooperation in the form of development of new drugs in the forerunner.
AKESO BIOPHARMA
Social Links:
Industry:
Biopharma Biotechnology Health Care
Founded:
2012-01-01
Address:
Zhongshan, Anhui, China
Country:
China
Website Url:
http://www.akesobio.com
Total Employee:
501+
Status:
Active
Contact:
0760-8987 3998
Email Addresses:
[email protected]
Total Funding:
219.97 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Google Tag Manager Google Analytics SSL By Default Global Site Tag HSTS Google Analytics 4
Similar Organizations
Aduro BioTech
Aduro BioTech is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Dare Bioscience
Daré Bioscience is a healthcare company committed to the development and commercialization of innovative products.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Idorsia
The purpose of Idorsia is to discover, develop and commercialize innovative medicines to help more patients.
InspireMD
InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard.
Kamada
Kamada is a biopharmaceutical company engaged in developing, producing and marketing of specialty life-saving therapeutics, using a unique
Liquidia Technologies
Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Current Employees Featured
Founder
Stock Details
Investors List
BOCOM International
BOCOM International investment in Series D - Akeso Biopharma
OrbiMed
OrbiMed investment in Series D - Akeso Biopharma
Loyal Valley Capital
Loyal Valley Capital investment in Series D - Akeso Biopharma
Apricot Capital
Apricot Capital investment in Series D - Akeso Biopharma
CDG International Company
CDG International Company investment in Series D - Akeso Biopharma
K. Wah Group
K. Wah Group investment in Series D - Akeso Biopharma
AIHC Capital
AIHC Capital investment in Series D - Akeso Biopharma
Shenzhen Capital Group
Shenzhen Capital Group investment in Series D - Akeso Biopharma
Lake Bleu Capital
Lake Bleu Capital investment in Series D - Akeso Biopharma
Sino Biopharmaceutical
Sino Biopharmaceutical investment in Series D - Akeso Biopharma
Official Site Inspections
http://www.akesobio.com Semrush global rank: 2.51 M Semrush visits lastest month: 7.37 K
- Host name: 42.159.132.179
- IP address: 42.159.132.179
- Location: Shanghai China
- Latitude: 31.0449
- Longitude: 121.4012
- Timezone: Asia/Shanghai
More informations about "Akeso Biopharma"
Akeso, Inc | Home
Akeso, Inc. (HKEX Code: 9926. HK) is a biopharmaceutical company founded by a team of scientists with rich experience in global drug development and focuses on the unmet clinical needs worldwide in major diseases.See details»
Akeso, Inc | Corporate Profile
CTTQ Akesobio Akeso Pharma AD Pharmaceuticals Contact Us Akeso, Inc. (9926.HK), established in 2012, is a biopharmaceutical company dedicated to the research, development, …See details»
Akesobio
康方生物由经验丰富的国际化团队创建，聚焦肿瘤、自身免疫、炎症、代谢疾病等重大疾病领域，专注于全球未被满足的临床需求， 打造了独有的端对端康方全方位新药研究开发平 …See details»
Akeso, Inc | Home
Akeso,Inc. (HKEX Code: 9926.HK) is a clinical-stage biopharmaceutical company committed to in-house discovery, development and commercialization of first-in-class and best-in-class …See details»
Akeso Company Profile | Management and Employees List
[email protected]: Akeso Top Competitors. Company Employees Revenue Top technologies; Adagene Inc. n/a: $22.7 M: KYTHERA Biopharmaceuticals Inc. n/a: $14.7 M: Seventh Wave …See details»
Akeso Biopharma - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 0760-8987 3998 The company has built a global level of bio-pharmaceutical research and development and industrialization platform; …See details»
Akeso, Inc. (HKG: 9926) Company Profile & Overview - Stock Analysis
Nov 22, 2024 Akeso, Inc., a biopharmaceutical company, researches, develops, manufactures, and commercializes antibody drugs. The company develops AK104, a PD-1/CTLA-4 bi …See details»
Akesobio - Products, Competitors, Financials, Employees, …
Akesobio serves the healthcare sector with a focus on developing treatments for diseases including tumors, autoimmune diseases, and metabolic disorders. It was founded in 2012 and …See details»
Akeso - Company Profile - Tracxn
Oct 11, 2024 Email ID: *****@akesobio.com; Key Metrics. Total Funding. $195M in 4 rounds. Latest Funding Round. Series D, Nov 01, 2019, $150M. Investors. Orbimed & 17 more. …See details»
Akeso - Overview, News & Similar companies | ZoomInfo.com
Akeso contact info: Phone number: +86 2021140336 Website: www.akesobio.com What does Akeso do? Akeso is a biopharmaceutical company dedicated to the research, development, …See details»
Akesobio, Inc. Company Profile | Daly City, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Akesobio, Inc. of Daly City, CA. Get the latest business insights from Dun & Bradstreet.See details»
Management Team - Akeso, Inc
Since its inception in 2012, Akeso has established the unique end-to-end Akeso Comprehensive Exploration Platform (ACE Platform). With a research and development innovation system …See details»
Akeso Biopharma - Craft
Akeso Biopharma $230.58 m in total funding,. See insights on Akeso Biopharma including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Summit Therapeutics Closes Deal with Akeso Inc. to In-License
Jan 20, 2023 Summit Therapeutics’ Mission Statement To build a viable, long-lasting health care organization that assumes full responsibility for designing, developing, trial execution and …See details»
Akeso Presented Promising Results of Cadonilimab and Lenvatinib …
Jan 23, 2024 Akeso, Inc. (9926.HK) ("Akeso," "we," or the "Company") today announced that the Company presented the promising phase II results of cadonilimab (a tetravalent PD-1/CTLA-4 …See details»
Akeso, Inc | Presentations
Feedback ? Tell us what you think about our. company, products, or websiteSee details»
Summit Therapeutics Partners with Akeso Inc. in Deal for Up
Dec 6, 2022 To build a viable, long-lasting health care organization that assumes full responsibility for designing, developing, trial execution and enrollment, regulatory submission …See details»
Akeso, Inc. Has Made Positive Progress on Bispecific Antibody with ...
On August 24, Akeso, Inc. announced that the registered Phase II clinical research of its independently-developed global first new tumor immunotherapy drug, Cadonilimab (PD …See details»
Collaborations - Akeso, Inc
To speed up the development and commercialization and maximize the clinical and commercial value of our innovative products, we have been identifying strategic partners globally with high …See details»
Akeso, Inc | Akeso Inc. Announces Collaboration and License …
Dec 6, 2022 [email protected] About Summit Therapeutics. Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in …See details»